About Vigilant Biosciences
Vigilant Biosciences is a company based in Fort Lauderdale (United States) founded in 2011.. Vigilant Biosciences has raised $29.76 million across 5 funding rounds from investors including White Owl Capital, venVelo and Florida Institute. Vigilant Biosciences offers products and services including BeVigilant OraFusion System. Vigilant Biosciences operates in a competitive market with competitors including Personalis, Geneoscopy, Viome Life Sciences, Saladax and Overture Life, among others.
- Headquarter Fort Lauderdale, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$29.76 M (USD)
in 5 rounds
-
Latest Funding Round
$17.26 M (USD), Series B
May 31, 2018
-
Investors
White Owl Capital
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vigilant Biosciences
Vigilant Biosciences offers a comprehensive portfolio of products and services, including BeVigilant OraFusion System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Point-of-care test for early detection of oral cancer biomarkers.
Unlock access to complete
Unlock access to complete
Funding Insights of Vigilant Biosciences
Vigilant Biosciences has successfully raised a total of $29.76M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $17.26 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $17.3M
-
First Round
First Round
(25 Mar 2014)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2018 | Amount | Series B - Vigilant Biosciences | Valuation |
investors |
|
| Feb, 2016 | Amount | Series B - Vigilant Biosciences | Valuation |
investors |
|
| Mar, 2015 | Amount | Series B - Vigilant Biosciences | Valuation | Florida Institute , White Owl Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vigilant Biosciences
Vigilant Biosciences has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include White Owl Capital, venVelo and Florida Institute. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech and energy companies in the US are funded.
|
Founded Year | Domain | Location | |
|
Early stage tech & life sciences focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Support is provided for Florida's technology ventures and innovation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vigilant Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vigilant Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vigilant Biosciences Comparisons
Competitors of Vigilant Biosciences
Vigilant Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Personalis, Geneoscopy, Viome Life Sciences, Saladax and Overture Life, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Non-invasive biomarker tests for colorectal cancer are developed.
|
|
| domain | founded_year | HQ Location |
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
|
|
| domain | founded_year | HQ Location |
Diagnostic tests for personalized oncology chemotherapy are provided.
|
|
| domain | founded_year | HQ Location |
Embryology diagnosis devices are developed for medical professionals.
|
|
| domain | founded_year | HQ Location |
Sensitive multiplex platforms for QPCR are developed using toehold probes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Vigilant Biosciences
When was Vigilant Biosciences founded?
Vigilant Biosciences was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Where is Vigilant Biosciences located?
Vigilant Biosciences is headquartered in Fort Lauderdale, United States. It is registered at Fort Lauderdale, Florida, United States.
Is Vigilant Biosciences a funded company?
Vigilant Biosciences is a funded company, having raised a total of $29.76M across 5 funding rounds to date. The company's 1st funding round was a Series B of $5.5M, raised on Mar 25, 2014.
What does Vigilant Biosciences do?
Vigilant Biosciences was founded in 2011 and is headquartered in Fort Lauderdale, United States. Operations focus on the biotechnology sector, where point-of-care and laboratory solutions are created for the early detection and intervention of oral cancer. The OncAlert Oral Cancer System, utilizing patented technology to identify CD44 and Total Protein markers, involves a non-invasive oral rinse procedure. This system is currently undergoing CE Mark registration approval.
Who are the top competitors of Vigilant Biosciences?
Vigilant Biosciences's top competitors include Personalis, Geneoscopy and Viome Life Sciences.
What products or services does Vigilant Biosciences offer?
Vigilant Biosciences offers BeVigilant OraFusion System.
Who are Vigilant Biosciences's investors?
Vigilant Biosciences has 3 investors. Key investors include White Owl Capital, venVelo, and Florida Institute.